与ECT相比,德克斯梅德托米丁的抗抑郁作用在治疗耐药抑郁症患者中较大
Journal of affective disorders
|November 24, 2023
概括
德克斯梅德托米丁 (DEX) 显示出快速和持久的抗抑郁作用,与治疗耐药性抑郁症 (TRD) 的电疗法 (ECT) 相似. 与ECT相比,DEX更快,副作用更少地实现了显著的症状改善.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 耐治疗抑郁症 (TRD) 是一个重大的临床挑战.
- 电疗法 (ECT) 是TRD的常见治疗方法,但具有局限性.
- 选择性α2-上腺素受体激动剂正在研究抗抑郁作用.
研究的目的:
- 在TRD患者中研究德克斯梅托米丁 (DEX) 的抗抑郁疗效.
- 在TRD患者中比较DEX输液与ECT的效果.
- 评估抗抑郁药效应的发病速度和持续时间.
主要方法:
- 一项试点研究涉及76名TRD患者,随机分配给DEX输液或ECT.
- 治疗包括10个会议在一个定义的时间.
- 主要结局:24项汉密尔顿抑郁评分表 (HDRS-24) 评分的变化.
主要成果:
- 无论DEX和ECT都显著改善了治疗后和3个月的随访后的HDRS-24得分.
- 没有观察到DEX和ECT之间的有效性有显著差异.
- 德克斯表现出更快的起作用,在2次治疗后达到轻度抑郁,而在ECT时达到6次.
结论:
- 德克斯梅德托米丁 (DEX) 对TRD提供快速和持久的抗抑郁作用.
- 德克斯 (DEX) 的疗效与ECT相当,但副作用的概况可能更好.
- 德克斯代表了对治疗耐药抑郁症患者的有前途的替代治疗方法.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
248
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
248
Sedatives and Hypnotics Drugs: Miscellaneous Agents
180
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
180
Electroconvulsive Therapy
44
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
44
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
403
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
403
Antiepileptic Drugs: Potassium Channel Activators
188
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
188
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
304
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
304


